3 Outperforming Stocks to Buy With $500 Right Now With a budget of around $500, investors can scoop up these three standout stock picks, which have outperformed the broader market in the past year. Barchart · Jul 30, 2024
Maker Of Pfizer's COVID-19 Vaccine mRNA-Delivery Tech Sues Arbutus Biopharma: Reuters Canada-based Acuitas Therapeutics Inc has sued Arbutus Biopharma Corporation (NASDAQ: ABUS) in Manhattan federal court, seeking to head off claims that the vaccine infringes Arbutus' patents, Benzinga · Mar 18, 2022
Arbutus Hits Moderna With New Suit Claiming COVID-19 Vaccine Patent(s) Arbutus Biopharma Corporation (NASDAQ: ABUS) and Genevant have sued Moderna Inc (NASDAQ: MRNA) for Benzinga · Feb 28, 2022